Dusa Pharmaceuticals (DUSA) Tops Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts DUSA Hot Sheet
Price: $57.29 +1.18%
Financial Fact:
NET INCOME (LOSS): -1.42M
Today's EPS Names:
RCBC, GASS, YSG, More
Financial Fact:
NET INCOME (LOSS): -1.42M
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
Dusa Pharmaceuticals (NASDAQ: DUSA) reported Q2 EPS of $0.09, $0.07 better than the analyst estimate of $0.02. Revenue for the quarter came in at $9.76 million versus the consensus estimate of $10.3 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Methode Electronics (MEI) Tops Q1 EPS by 2c; offers guidance
- Five Below (FIVE) Tops Q2 EPS by 35c, Beats on Revenue; Offers Q3 Revenue Guidance
- Ollie's Bargain Outlet (OLLI) Tops Q2 EPS by 28c, Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
